{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:58Z","timestamp":1791838198101,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-025-06360-8","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T03:17:41Z","timestamp":1744687061000},"page":"2229-2238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised \u03b2-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1988-0093","authenticated-orcid":false,"given":"Anwar","family":"Al-Awadhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Materah Salem","family":"Alwehaidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefayah","family":"Al-Sabaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Al-Ajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"6","key":"6360_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/gim.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa R (2017) \u03b2-Thalassemia. Genet Sci 19(6):609\u2013619. https:\/\/doi.org\/10.1038\/gim.2016.173","journal-title":"Genet Sci"},{"key":"6360_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/26348535221103560","author":"PK Yadav","year":"2022","unstructured":"Yadav PK, Singh AK (2022) A review of iron overload in Beta-Thalassemia major, and a discussion on alternative potent iron chelation targets. Plasmatology. https:\/\/doi.org\/10.1177\/26348535221103560. 26;16","journal-title":"Plasmatology"},{"issue":"6","key":"6360_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00277-019-03618-w","volume":"98","author":"F Koohi","year":"2019","unstructured":"Koohi F, Kazemi T, Miri-Moghaddam E (2019) Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis. Ann Hematol 98(6):1323\u20131331. https:\/\/doi.org\/10.1007\/s00277-019-03618-w","journal-title":"Ann Hematol"},{"issue":"4","key":"6360_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1573399811309040005","volume":"9","author":"V De Sanctis","year":"2013","unstructured":"De Sanctis V, Soliman A, Yassin M (2013) Iron overload and glucose metabolism in subjects with \u03b2-thalassaemia major: an overview. Curr Diabetes Rev 9(4):332\u2013341. https:\/\/doi.org\/10.2174\/1573399811309040005","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"6360_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5144\/0256-4947.2013.18","volume":"33","author":"KM Belhoul","year":"2013","unstructured":"Belhoul KM, Bakir ML, Kadhim AM, Dewedar HE, Eldin MS, Alkhaja FA (2013) Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai thalassemia centre. Ann Saudi Med 33(1):18\u201321. https:\/\/doi.org\/10.5144\/0256-4947.2013.18","journal-title":"Ann Saudi Med"},{"issue":"3","key":"6360_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/ehm.11.29","volume":"4","author":"C Borgna-Pignatti","year":"2011","unstructured":"Borgna-Pignatti C, Gamberini MR (2011) Complications of thalassemia major and their treatment. Expert Rev Hematol 4(3):353\u2013366. https:\/\/doi.org\/10.1586\/ehm.11.29","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"6360_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1160\/TH06-05-0267","volume":"96","author":"A Taher","year":"2006","unstructured":"Taher A, Isma\u2019eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA et al (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the mediterranean area and Iran. Thromb Haemost 96(4):488\u2013491","journal-title":"Thromb Haemost"},{"issue":"17","key":"6360_CR8","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","volume":"117","author":"T Ganz","year":"2011","unstructured":"Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117(17):4425\u20134433. https:\/\/doi.org\/10.1182\/blood-2011-01-258467","journal-title":"Blood"},{"issue":"2\u20133","key":"6360_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000243791","volume":"122","author":"E Nemeth","year":"2009","unstructured":"Nemeth E, Ganz T (2009) The role of Hepcidin in iron metabolism. Acta Haematol 122(2\u20133):78\u201386. https:\/\/doi.org\/10.1159\/000243791","journal-title":"Acta Haematol"},{"issue":"7","key":"6360_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI15686","volume":"110","author":"G Nicolas","year":"2002","unstructured":"Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide Hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110(7):1037\u20131044. https:\/\/doi.org\/10.1172\/JCI15686","journal-title":"J Clin Invest"},{"issue":"8","key":"6360_CR11","doi-asserted-by":"publisher","first-page":"e1004998","DOI":"10.1371\/journal.ppat.1004998","volume":"11","author":"K Michels","year":"2015","unstructured":"Michels K, Nemeth E, Ganz T, Mehrad B (2015) Hepcidin and host defense against infectious diseases. PLoS Pathog 11(8):e1004998. https:\/\/doi.org\/10.1371\/journal.ppat.1004998","journal-title":"PLoS Pathog"},{"issue":"1","key":"6360_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood.v99.1.36","volume":"99","author":"A Eldor","year":"2002","unstructured":"Eldor A, Rachmilewitz EA (2002) The hypercoagulable state in thalassemia. Blood 99(1):36\u201343. https:\/\/doi.org\/10.1182\/blood.v99.1.36","journal-title":"Blood"},{"issue":"3","key":"6360_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12291-016-0620-7","volume":"32","author":"A Kumar","year":"2017","unstructured":"Kumar A, Batra HS, Banerjee M, Bandyopadhyay S, Saha TK, Misra P, Ambade V (2017) PAI-1 study in thalassemia major patients receiving multiple blood transfusion. IJCB 32(3):343\u2013346. https:\/\/doi.org\/10.1007\/s12291-016-0620-7","journal-title":"IJCB"},{"issue":"7","key":"6360_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1046\/j.1538-7836.2003.00260.x","volume":"1","author":"ZM Ruggeri","year":"2003","unstructured":"Ruggeri ZM (2003) Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemostasis: JTH 1(7):1335\u20131342. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00260.x","journal-title":"J Thromb Haemostasis: JTH"},{"key":"6360_CR15","doi-asserted-by":"publisher","first-page":"107602962199212","DOI":"10.1177\/1076029621992128","volume":"27","author":"DA Bashir","year":"2021","unstructured":"Bashir DA, Da Q, Pradhan S, Sekhar N, Valladolid C, Lam F, Guffey D, Goldman J, Desai MS, Cruz MA, Allen C, Nguyen TC, Vijayan KV (2021) Secretion of von Willebrand factor and suppression of ADAMTS-13 activity by markedly high concentration of ferritin. Clin Appl Thromb Hemost 27:1076029621992128. https:\/\/doi.org\/10.1177\/1076029621992128","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"6360_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","volume":"16","author":"R Kelwick","year":"2015","unstructured":"Kelwick R, Desanlis I, Wheeler GN, Edwards DR (2015) The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 16(1):113. https:\/\/doi.org\/10.1186\/s13059-015-0676-3","journal-title":"Genome Biol"},{"key":"6360_CR17","doi-asserted-by":"publisher","unstructured":"Chen X, Cheng X, Zhang S, Wu D (2019) Adamts13: an emerging target in stroke therapy. Front Neurol 10. https:\/\/doi.org\/10.3389\/fneur.2019.00772","DOI":"10.3389\/fneur.2019.00772"},{"issue":"5","key":"6360_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jtha.2023.01.024","volume":"21","author":"MS Edvardsen","year":"2023","unstructured":"Edvardsen MS, Hansen ES, Ueland T, Aukrust P, Br\u00e6kkan SK, Morelli VM, Hansen JB (2023) Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism. J Thromb Haemostasis: JTH 21(5):1227\u20131237. https:\/\/doi.org\/10.1016\/j.jtha.2023.01.024","journal-title":"J Thromb Haemostasis: JTH"},{"issue":"9","key":"6360_CR19","doi-asserted-by":"publisher","first-page":"CD010517","DOI":"10.1002\/14651858.CD010517.pub3","volume":"9","author":"A Sharma","year":"2019","unstructured":"Sharma A, Easow Mathew M, Puri L (2019) Splenectomy for people with thalassaemia major or intermedia. Cochrane Database Syst Rev 9(9):CD010517. https:\/\/doi.org\/10.1002\/14651858.CD010517.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"6360_CR20","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood 118(13):3479\u20133488. https:\/\/doi.org\/10.1182\/blood-2010-08-300335","journal-title":"Blood"},{"issue":"4","key":"6360_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1365-2257.2003.00523.x)","volume":"25","author":"K Sukhu","year":"2003","unstructured":"Sukhu K, Poovalingam V, Mahomed R, Giangrande PL (2003) Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol 25(4):247\u2013249. https:\/\/doi.org\/10.1046\/j.1365-2257.2003.00523.x)","journal-title":"Clin Lab Haematol"},{"issue":"6","key":"6360_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/ijlh.14135","volume":"45","author":"K Al-Sabaan","year":"2023","unstructured":"Al-Sabaan K, Al-Awadhi A (2023) Evaluating von Willebrand factor and ADAMTS13 levels in thalassemia major patients and assessing a possible association with Thrombospondin-1. Int J Lab Hematol 45(6):945\u2013952. https:\/\/doi.org\/10.1111\/ijlh.14135","journal-title":"Int J Lab Hematol"},{"key":"6360_CR23","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.89313","author":"R Natesirinilkul","year":"2020","unstructured":"Natesirinilkul R (2020) Thromboembolism in Beta-Thalassemia disease. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.89313","journal-title":"IntechOpen"},{"issue":"11","key":"6360_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.apjtm.2016.07.035","volume":"9","author":"K Leecharoenkiat","year":"2016","unstructured":"Leecharoenkiat K, Lithanatudom P, Sornjai W, Smith DR (2016) Iron dysregulation in beta-thalassemia. Asian Pac J Trop Med 9(11):1035\u20131043. https:\/\/doi.org\/10.1016\/j.apjtm.2016.07.035","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"6360_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1182\/blood-2014-10-606491","volume":"125","author":"E Jones","year":"2015","unstructured":"Jones E, Pasricha SR, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C, Sturges P, Olivieri NF, St Pierre T, Armitage AE, Porter JB, Weatherall DJ, Drakesmith H (2015) Hepcidin is suppressed by erythropoiesis in hemoglobin E \u03b2-thalassemia and \u03b2-thalassemia trait. Blood 125(5):873\u2013880. https:\/\/doi.org\/10.1182\/blood-2014-10-606491","journal-title":"Blood"},{"issue":"10","key":"6360_CR26","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","volume":"105","author":"G Papanikolaou","year":"2005","unstructured":"Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E (2005) Hepcidin in iron overload disorders. Blood 105(10):4103\u20134105. https:\/\/doi.org\/10.1182\/blood-2004-12-4844","journal-title":"Blood"},{"issue":"1","key":"6360_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","volume":"122","author":"SR Pasricha","year":"2013","unstructured":"Pasricha SR, Frazer DM, Bowden DK, Anderson GJ (2013) Transfusion suppresses erythropoiesis and increases Hepcidin in adult patients with \u03b2-thalassemia major: a longitudinal study. Blood 122(1):124\u2013133. https:\/\/doi.org\/10.1182\/blood-2012-12-471441","journal-title":"Blood"},{"issue":"20","key":"6360_CR28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/01.CIR.0000066910.02844.D0","volume":"107","author":"SM Day","year":"2003","unstructured":"Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP (2003) Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107(20):2601\u20132606. https:\/\/doi.org\/10.1161\/01.CIR.0000066910.02844.D0","journal-title":"Circulation"},{"issue":"1","key":"6360_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms17010130","volume":"17","author":"R Gozzelino","year":"2016","unstructured":"Gozzelino R, Arosio P (2016) Iron homeostasis in health and disease. Int J Mol Sci 17(1):130. https:\/\/doi.org\/10.3390\/ijms17010130","journal-title":"Int J Mol Sci"},{"issue":"11","key":"6360_CR30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1182\/bloodadvances.2018018465","volume":"2","author":"TS Ellingsen","year":"2018","unstructured":"Ellingsen TS, Lappeg\u00e5rd J, Ueland T, Aukrust P, Br\u00e6kkan SK, Hansen JB (2018) Plasma Hepcidin is associated with future risk of venous thromboembolism. Blood Adv 2(11):1191\u20131197. https:\/\/doi.org\/10.1182\/bloodadvances.2018018465","journal-title":"Blood Adv"},{"issue":"4","key":"6360_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(sici)1096-8652(199904)60:4<289::aid-ajh7>3.0.co;2-w","volume":"60","author":"R Fischer","year":"1999","unstructured":"Fischer R, Tiemann CD, Engelhardt R, Nielsen P, D\u00fcrken M, Gabbe EE, Janka GE (1999) Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol 60(4):289\u2013299. https:\/\/doi.org\/10.1002\/(sici)1096-8652(199904)60:4%3C289::aid-ajh7%3E3.0.co;2-w","journal-title":"Am J Hematol"},{"issue":"2","key":"6360_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1182\/blood-2007-08-109306","volume":"111","author":"AR Cohen","year":"2008","unstructured":"Cohen AR, Glimm E, Porter JB (2008) Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood 111(2):583\u2013587. https:\/\/doi.org\/10.1182\/blood-2007-08-109306","journal-title":"Blood"},{"issue":"5","key":"6360_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/MPH.0b013e31820c34ef","volume":"33","author":"Y Aydinok","year":"2011","unstructured":"Aydinok Y, Bayraktaroglu S, Yildiz D, Alper H (2011) Myocardial iron loading in patients with thalassemia major in Turkey and the potential role of splenectomy in myocardial siderosis. J Pediatr Hematol Oncol 33(5):374\u2013378. https:\/\/doi.org\/10.1097\/MPH.0b013e31820c34ef","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"6360_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1365-2141.2001.02482.x","volume":"112","author":"D Tavazzi","year":"2001","unstructured":"Tavazzi D, Duca L, Graziadei G, Comino A, Fiorelli G, Cappellini MD (2001) Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes. Br J Haematol 112(1):48\u201350. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02482.x","journal-title":"Br J Haematol"},{"issue":"4","key":"6360_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/1110-1121.147614","volume":"33","author":"S Ammar","year":"2014","unstructured":"Ammar S, Elsayh K, Embaby M, Zahran A (2014) Splenectomy for patients with \u03b2-thalassemia major: long-term outcomes. Egypt J Surg 33(4):232\u2013236","journal-title":"Egypt J Surg"},{"issue":"15","key":"6360_CR36","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3889\/oamjms.2019.636","volume":"7","author":"NA Ismail","year":"2019","unstructured":"Ismail NA, Habib SA, Talaat AA, Mostafa NO, Elghoroury EA (2019) The relation between serum Hepcidin, ferritin, Hepcidin: ferritin ratio, hydroxyurea and splenectomy in children with \u03b2-Thalassemia. Open Access Maced J Med Sci 7(15):2434\u20132439. https:\/\/doi.org\/10.3889\/oamjms.2019.636","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"6360_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ejh.12121","volume":"91","author":"M Casale","year":"2013","unstructured":"Casale M, Cinque P, Ricchi P, Costantini S, Spasiano A, Prossomariti L, Minelli S, Frega V, Filosa A (2013) Effect of splenectomy on iron balance in patients with \u03b2-thalassemia major: a long-term follow-up. Eur J Haematol 91(1):69\u201373. https:\/\/doi.org\/10.1111\/ejh.12121","journal-title":"Eur J Haematol"},{"key":"6360_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1196\/annals.1345.039","volume":"1054","author":"MD Cappellini","year":"2005","unstructured":"Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G (2005) Coagulation and splenectomy: an overview. Ann N Y Acad Sci 1054:317\u2013324. https:\/\/doi.org\/10.1196\/annals.1345.039","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"6360_CR39","doi-asserted-by":"publisher","first-page":"e2011025","DOI":"10.4084\/MJHID.2011.025","volume":"3","author":"J Succar","year":"2011","unstructured":"Succar J, Musallam KM, Taher AT (2011) Thalassemia and venous thromboembolism. Mediterr J Hematol Infect Dis 3(1):e2011025. https:\/\/doi.org\/10.4084\/MJHID.2011.025","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"6360_CR40","doi-asserted-by":"publisher","first-page":"1259785","DOI":"10.3389\/fmed.2023.1259785","volume":"10","author":"TV Kalamara","year":"2023","unstructured":"Kalamara TV, Dodos K, Vlachaki E (2023) Splenectomy is significantly associated with thrombosis but not with pulmonary hypertension in patients with transfusion-dependent thalassemia: a meta-analysis of observational studies. Front Med (Lausanne) 10:1259785. https:\/\/doi.org\/10.3389\/fmed.2023.1259785","journal-title":"Front Med (Lausanne)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06360-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06360-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06360-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:13:43Z","timestamp":1746414823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06360-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6360"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06360-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by Kuwait Ministry of Health and Kuwait University ethical committee. Informed, signed consent was obtained from all participating subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}